Physician profile
Michael Halko
NPI 1891155818
$1,530.67
in general payments reported to CMS, 2019-2025
22 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $32.55 · 2021: $441 · 2022: $156 · 2023: $99.83 · 2024: $186 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $334.87 | 2021-2025 | Freestyle Libre 2 |
| Abbvie INC. | $173.94 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $139.52 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.12 | 2019-2023 | |
| Novo Nordisk INC | $91.03 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $81.31 | 2019-2021 | |
| Amgen INC. | $80.78 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $79.04 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $59.55 | 2019 | |
| Pfizer INC. | $50.03 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $49.09 | 2019-2022 | |
| Lilly USA, LLC | $43.00 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.57 | 2019 | |
| Amarin Pharma, INC. | $40.36 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.82 | 2021-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $28.83 | 2019-2024 | Bexsero |
| Janssen Pharmaceuticals, INC | $26.77 | 2020-2021 | |
| Genentech USA, INC. | $19.12 | 2020 | |
| Exact Sciences Corporation | $17.94 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $16.76 | 2024 | Veozah |
| Xeris Pharmaceuticals, INC. | $16.09 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Halko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.